Basic Information
| LncRNA/CircRNA Name | circ_0000419 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | exosome | ||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR |
| Sample | gastric cancer tissues, cell lines and plasma |
| Expression Pattern | down-regulated |
| Function Description | Hsa_circ_0000419 levels were significantly decreased in GC cell lines, cancer tissues and plasma from GC patients. GC tissues hsa_circ_0000419 levels were associated with cell differentiation, Borrmann type, overall survival and disease-free survival, whereas plasma hsa_circ_0000419 were significantly correlated with tumor stage, lymphatic and distal metastasis, venous and perineural invasion. Plasma hsa_circ_0000419 exists in exosomes and maintain good stability. |
| Pubmed ID | 31810586 |
| Year | 2020 |
| Title | Clinical significance of hsa_circ_0000419 in gastric cancer screening and prognosis estimation |
External Links
| Links for circ_0000419 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |